These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

792 related items for PubMed ID: 25728808

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection.
    Youngster I, Russell GH, Pindar C, Ziv-Baran T, Sauk J, Hohmann EL.
    JAMA; 2014 Nov 05; 312(17):1772-8. PubMed ID: 25322359
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
    Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, Stollman N, Rohlke F, Surawicz C.
    Am J Gastroenterol; 2012 Jul 05; 107(7):1079-87. PubMed ID: 22450732
    [Abstract] [Full Text] [Related]

  • 5. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results.
    Kelly CR, de Leon L, Jasutkar N.
    J Clin Gastroenterol; 2012 Feb 05; 46(2):145-9. PubMed ID: 22157239
    [Abstract] [Full Text] [Related]

  • 6. Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy.
    Jiang ZD, Ajami NJ, Petrosino JF, Jun G, Hanis CL, Shah M, Hochman L, Ankoma-Sey V, DuPont AW, Wong MC, Alexander A, Ke S, DuPont HL.
    Aliment Pharmacol Ther; 2017 Apr 05; 45(7):899-908. PubMed ID: 28220514
    [Abstract] [Full Text] [Related]

  • 7. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC, Koziel J, Dieterich W, Haziri D, Wirtz S, Glowczyk I, Konturek K, Neurath MF, Zopf Y.
    J Physiol Pharmacol; 2016 Dec 05; 67(6):859-866. PubMed ID: 28195066
    [Abstract] [Full Text] [Related]

  • 8. Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
    Hota SS, Sales V, Tomlinson G, Salpeter MJ, McGeer A, Coburn B, Guttman DS, Low DE, Poutanen SM.
    Clin Infect Dis; 2017 Feb 01; 64(3):265-271. PubMed ID: 28011612
    [Abstract] [Full Text] [Related]

  • 9. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience.
    Patel NC, Griesbach CL, DiBaise JK, Orenstein R.
    Mayo Clin Proc; 2013 Aug 01; 88(8):799-805. PubMed ID: 23910407
    [Abstract] [Full Text] [Related]

  • 10. Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT): a randomised, double-blind, placebo-controlled trial.
    Baunwall SMD, Andreasen SE, Hansen MM, Kelsen J, Høyer KL, Rågård N, Eriksen LL, Støy S, Rubak T, Damsgaard EMS, Mikkelsen S, Erikstrup C, Dahlerup JF, Hvas CL.
    Lancet Gastroenterol Hepatol; 2022 Dec 01; 7(12):1083-1091. PubMed ID: 36152636
    [Abstract] [Full Text] [Related]

  • 11. Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection--an observational cohort study.
    Satokari R, Mattila E, Kainulainen V, Arkkila PE.
    Aliment Pharmacol Ther; 2015 Jan 01; 41(1):46-53. PubMed ID: 25355279
    [Abstract] [Full Text] [Related]

  • 12. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate.
    Fischer M, Sipe BW, Rogers NA, Cook GK, Robb BW, Vuppalanchi R, Rex DK.
    Aliment Pharmacol Ther; 2015 Aug 01; 42(4):470-6. PubMed ID: 26096320
    [Abstract] [Full Text] [Related]

  • 13. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
    Ianiro G, Valerio L, Masucci L, Pecere S, Bibbò S, Quaranta G, Posteraro B, Currò D, Sanguinetti M, Gasbarrini A, Cammarota G.
    Clin Microbiol Infect; 2017 May 01; 23(5):337.e1-337.e3. PubMed ID: 28057560
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces].
    Nieuwdorp M, van Nood E, Speelman P, van Heukelem HA, Jansen JM, Visser CE, Kuijper EJ, Bartelsman JF, Keller JJ.
    Ned Tijdschr Geneeskd; 2008 Aug 30; 152(35):1927-32. PubMed ID: 18808083
    [Abstract] [Full Text] [Related]

  • 15. Fecal Microbiota Transplantation for Refractory and Recurrent Clostridium difficile Infection: A Case Series of Nine Patients.
    Bang BW, Park JS, Kim HK, Shin YW, Kwon KS, Kwon HY, Baek JH, Lee JS.
    Korean J Gastroenterol; 2017 Apr 25; 69(4):226-231. PubMed ID: 28449424
    [Abstract] [Full Text] [Related]

  • 16. Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
    Hvas CL, Dahl Jørgensen SM, Jørgensen SP, Storgaard M, Lemming L, Hansen MM, Erikstrup C, Dahlerup JF.
    Gastroenterology; 2019 Apr 25; 156(5):1324-1332.e3. PubMed ID: 30610862
    [Abstract] [Full Text] [Related]

  • 17. Fecal microbiota transplantation via colonoscopy for recurrent C. difficile Infection.
    Allegretti JR, Korzenik JR, Hamilton MJ.
    J Vis Exp; 2014 Dec 08; (94):. PubMed ID: 25549239
    [Abstract] [Full Text] [Related]

  • 18. Duodenal infusion of donor feces for recurrent Clostridium difficile.
    van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ.
    N Engl J Med; 2013 Jan 31; 368(5):407-15. PubMed ID: 23323867
    [Abstract] [Full Text] [Related]

  • 19. Fidaxomicin versus vancomycin for Clostridium difficile infection.
    Louie TJ, Miller MA, Mullane KM, Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK, OPT-80-003 Clinical Study Group.
    N Engl J Med; 2011 Feb 03; 364(5):422-31. PubMed ID: 21288078
    [Abstract] [Full Text] [Related]

  • 20. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial.
    Guery B, Menichetti F, Anttila VJ, Adomakoh N, Aguado JM, Bisnauthsing K, Georgopali A, Goldenberg SD, Karas A, Kazeem G, Longshaw C, Palacios-Fabrega JA, Cornely OA, Vehreschild MJGT, EXTEND Clinical Study Group.
    Lancet Infect Dis; 2018 Mar 03; 18(3):296-307. PubMed ID: 29273269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.